Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Shares Issued (2022 - 2025)

Stoke Therapeutics (STOK) has 4 years of Shares Issued data on record, last reported at $3.7 million in Q3 2025.

  • For Q3 2025, Shares Issued rose 2544.6% year-over-year to $3.7 million; the TTM value through Sep 2025 reached $3.4 million, up 195.34%, while the annual FY2024 figure was $532000.0, 43.4% up from the prior year.
  • Shares Issued reached $3.7 million in Q3 2025 per STOK's latest filing, up from $370000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $3.7 million in Q3 2025 and bottomed at -$623000.0 in Q4 2024.
  • Average Shares Issued over 4 years is $418692.3, with a median of $153000.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: crashed 15675.0% in 2024, then soared 2544.6% in 2025.
  • A 4-year view of Shares Issued shows it stood at -$76000.0 in 2022, then surged by 105.26% to $4000.0 in 2023, then plummeted by 15675.0% to -$623000.0 in 2024, then surged by 690.05% to $3.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $3.7 million in Q3 2025, $370000.0 in Q1 2025, and -$623000.0 in Q4 2024.